Scientists Move Closer to Solving Arthritic Condition in Teens

A new Michigan State University study has found that Malfunctioning Endoplasmic Reticulum Aminopeptidase 1, or ERAP1 gene associated with a common arthritic disease that often starts in teenagers is now directly linked to the loss of vital immune //cells that may prevent it. The findings of the study are published in Scientific Reports.

Also known as AS, the autoimmune disorder affects millions worldwide, mostly developing in the hips and spines of those as young as 17 years old and lasting throughout life.

Diet, Nutrition and Supplements for Osteo-Arthritis and Rheumatoid Arthritis
Rheumatoid arthritis patients should consume a diet rich in natural antioxidant and anti-inflammatory nutrients and avoid foods like sugar, saturated fats, and trans fatty acids.

‘Endoplasmic Reticulum Aminopeptidase 1, or ERAP1, is a gene widely known to be associated with the debilitating disease ankylosing spondylitis. ’

Tweet it Now

But how changes in the gene result in the condition has remained somewhat of a mystery.

"We've demonstrated in mice that loss of proper ERAP1 activity correlates with loss of certain immune cells called Tr1s, which we know are directly responsible for controlling excessive immune responses that can attack healthy tissue and cells," said Andrea Amalfitano, an Osteopathic Heritage Foundation professor who led the study with Yuliya Pepelyayeva, a doctoral student in MSU's microbiology and molecular genetics program. "Our finding allows us to zero in on the role the gene and Tr1 cells have in AS."

In the case of autoimmune disorders, the immune system can no longer tell the difference between good, healthy cells and bad, diseased cells. This often results in an extreme immune reaction where the body starts to overcompensate and attack itself.

Hip Replacement- Osteoarthritis, Post Operative Complications
Are you experiencing pain due to damaged hips? Travel abroad to get replacement surgery at affordable prices.

Because of this response, patients with AS experience bony fusions between the joints of the pelvis and spine, which cause chronic pain and disability. They also can suffer from other health issues including problems with the gut and intestine.

"We know that Tr1 cells are implicated in digestive issues such as inflammatory bowel disease, and it's possible that the reduction of these cells is responsible for the increased inflammatory responses we saw in mice and is associated with ankylosing spondylitis as well," Pepelyayeva said.

Quiz on Arthritis
Do you know that there are more than 100 types of arthritis? If you think that only old people suffer from arthritis, take this intriguing quiz to get your facts on arthritis.

With this new insight, both researchers are now testing cells in human blood samples and will move to human trials in the coming years to see if their findings are consistent.

"There's more work to be done, but a new immunotherapy treatment where more Tr1 cells are infused back into the patient, ultimately correcting the deficiency, could be a possibility," Pepelyayeva said.

New Drug To Treat Rheumatoid Arthritis
New drug upadacitinib drug showed improvements in joint swelling in patients with Rheumatoid Arthritis, an inflammatory condition that affects joints and tendons and is characterized by increased disease activity.

This new treatment, she added, would potentially help regulate the way the immune system responds and might correct any inflammation in the spine and spinal fusions.

Amalfitano also indicated that scientists can now focus on this potential relationship between gene and immune cell and look at it as a possible cause of not just AS, but several other autoimmune diseases, too.

The study was funded in part by the National Institutes of Health.

Source-Eurekalert